EMEA-000065-PIP01-07-M05

Key facts

Invented name
Sebivo
Active substance
telbivudine
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0152/2017
PIP number
EMEA-000065-PIP01-07-M05
Pharmaceutical form(s)
  • Film-coated tablet
  • Oral solution
Condition(s) / indication(s)
Treatment of chronic hepatitis B
Route(s) of administration
Oral use
Contact for public enquiries
Novartis Europharm Limited
Switzerland
Tel. +41 623241111
Fax +41 613248001
E-mail: paediatric.enquiries@novartis.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating